While Humana Inc has underperformed by -1.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HUM fell by -0.27%, with highs and lows ranging from $315.35 to $206.87, whereas the simple moving average fell by -2.19% in the last 200 days.
On October 14, 2025, Goldman started tracking Humana Inc (NYSE: HUM) recommending Sell. A report published by Evercore ISI on September 22, 2025, Initiated its previous ‘In-line’ rating for HUM. Raymond James also Upgraded HUM shares as ‘Outperform’, setting a target price of $315 on the company’s shares in a report dated May 01, 2025. BofA Securities November 06, 2024d the rating to Neutral on November 06, 2024, and set its price target from $247 to $308. KeyBanc Capital Markets initiated its ‘Sector Weight’ rating for HUM, as published in its report on October 11, 2024. Bernstein’s report from October 08, 2024 suggests a price prediction of $308 for HUM shares, giving the stock a ‘Outperform’ rating. TD Cowen also rated the stock as ‘Hold’.
Analysis of Humana Inc (HUM)
The current dividend for HUM investors is set at $3.54 per share, indicating investors will get a return regardless of how the company performs over the next quarter. Further, the quarter-over-quarter increase in sales is 11.06%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Humana Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of 7.15% is sufficient for you to turn a profit off your investment.
As an indicator of volatility for any stock, average volume can also be very valuable, and HUM is recording an average volume of 1.91M. On a monthly basis, the volatility of the stock is set at 3.78%, whereas on a weekly basis, it is put at 3.11%, with a gain of 2.86% over the past seven days. Furthermore, long-term investors anticipate a median target price of $283.92, showing growth from the present price of $253.02, which can serve as yet another indication of whether HUM is worth investing in or should be passed over.
How Do You Analyze Humana Inc Shares?
Humana Inc (HUM) is based in the USA and is one of the most prominent companies operating in the Healthcare Plans market. When comparing Humana Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 23.71, there is a growth in quarterly earnings of -59.37%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.22%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 96.80% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
